News

It is one thing to understand that space alters the human body; it is another to see it happen before one’s eyes, on people ...
Discover how inflammation peptides are revolutionising our understanding of immune regulation, offering new avenues for ...
In its latest earnings report, Iovance confirmed plans to reduce its workforce by 19% in a bid to save $100 million in yearly ...
A new study shows how the single-molecule organization of receptors in a cellular context determines the function of ...
PD-1 Inactivated TIL Cell Therapy (IOV-4001): Results are anticipated in the second half of 2025 from the Phase 2 efficacy portion of the IOV-GM1-201 trial in previously treated advanced melanoma.